Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01908907 · ClinicalTrials.gov registry record · NA
Bridging the Docosahexaenoic Acid (DHA) Gap: The Effects of Omega-3 Fatty Acid Supplementation in Premature Infants
A NA study, sponsored by Sanford Health.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01908907 is a NA study that has completed, run by Sanford Health. The registered enrollment target is 60 participants.
The verdict
NCT01908907, a NA study, has completed, sponsored by Sanford Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to understand if the "DHA gap" can be corrected by giving a daily dose of DHA oil to preterm babies. DHA is an essential omega-3 fatty acid, which means our body cannot make DHA. We have to take it in through our diet. DHA is important for normal brain and eye health and it may also decrease inflammation. This is important for premature babies because they are at a greater risk for getting diseases related to inflammation, especially in their lungs, eyes and intestines. Since DHA is so important for normal growth, you will find DHA naturally in breast milk and it is now added to infant formula. But the amount in breast milk and infant formula is about half of what your infant should expect to get in the womb (about 13-29mg per day in breast milk vs. 50-75mg per day in the womb). Very premature babies are at an even greater disadvantage because they cannot always eat very much right away and that is the only way they can get essential fatty acids in their body. This means premature babies are getting less DHA than they would in the womb and then the "DHA gap" continues for a longer period of time. This gap also comes at a time when their brain is growing most rapidly and their bodies need it the most. This trial is designed to see if giving DHA, even before the baby can take food orally, will raise his/her DHA blood levels to those of normal term babies.
Interventions
- DIETARY_SUPPLEMENT DHA oil
- DIETARY_SUPPLEMENT (MCT) Control oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01908907
The ClinicalTrials.gov registry entry for NCT01908907 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DHA oil is the first listed.
NCT01908907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01908907 about?
NCT01908907 is a clinical study titled "Bridging the Docosahexaenoic Acid (DHA) Gap: The Effects of Omega-3 Fatty Acid Supplementation in Premature Infants". The purpose of this study is to understand if the "DHA gap" can be corrected by giving a daily dose of DHA oil to preterm babies. DHA is an essential omega-3 fatty acid, which means our body cannot make DHA. We have to take it in through our diet. DHA is important for normal brain and eye health an...
What is the current status of trial NCT01908907?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-10. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01908907?
The interventions under investigation include: DHA oil (DIETARY_SUPPLEMENT), (MCT) Control oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01908907?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.